Diseases & Disorders
(G99)
IRS Verified
DX Registered
990 on File
SIEGEL RARE NEUROIMMUNE ASSOCIATION
Financial strength (30%)
85/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To support and advocate for individuals and their families diagnosed with rare neuroimmunologic disorders of the central nervous system To promote awareness and to empower patients, families, clinicians and scientists through education programs and publications To advance the scientific understanding of and therapy development for these rare disorders by supporting the training of clinicians-scientists dedicated to these rare diseases and by supporting basic and clinical research OUR GOAL IS TO IMPROVE THE QUALITY OF LIFE OF INDIVIDUALS WITH THESE RARE NEUROIMMUNOLOGIC DISORDERS
Financial Overview — FY 2023
$1.3M
Total Revenue
$1.2M
Total Expenses
$1.6M
Net Assets
7
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.6%
Fundraising Efficiency
N/A
Operating Reserve
15.62x
Liability-to-Asset
7.4%
Revenue Diversification
96.2%
Executive Compensation
$211K
Compared with Peers
FY 2023
Compared with 882 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.6% | 83.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.2% | 11.4% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.2% | 2.2% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
15.6 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
7.4% | 13.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.2% | 89.5% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
4.3% | 8.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
11.8% | 11.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
3.5% | 1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.3M | $1.2M | $1.6M | 88.6% | 7 |
| 2022 | $1.2M | $1.1M | $1.6M | 87.6% | 7 |
| 2021 | $2.7M | $683K | N/A | — | 7 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.